Email this article 
Review Articles
Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): an update
South African Family Practice | Vol 58, No 5 : September/October| a4570 |
DOI: https://doi.org/10.4102/safp.v58i5.4570
| © 2016 O. Mogole, N. Schellack, M. H. Motswaledi
| This work is licensed under Other
Submitted: 21 September 2016 | Published: 02 November 2016
Submitted: 21 September 2016 | Published: 02 November 2016
About the author(s)
O. Mogole, Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, South AfricaN. Schellack, Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, South Africa
M. H. Motswaledi, Department of Dermatology, Faculty of Medicine, Sefako Makgatho Health Sciences University, South Africa
Full Text:
PDF (82KB)Abstract
Stevens-Johnson syndrome (SJS) is a form of toxic epidermal necrolysis (TEN) a rare but life-threatening hypersensitivity reactions that affect the skin and mucous membranes. The most common triggers are drugs, but they can also be triggered by infections. Granulysin has been recently identified as the major molecule responsible for the widespread keratinocyte necrosis. Early identification and removal of causative agent is crucial in preventing progression of condition and reducing patient mortality. Supportive care is often recommended over immunomodulating treatments as it helps improve patient outcome.
Keywords
Steven-Johnsons syndrome (SJS); toxic epidermal necrolysis (TEN); granulysin; supportive care; hypersensitivity; immunomodulating
Metrics
Total abstract views: 4431Total article views: 1664
